UCB · UCB S.A.
208.10
EURUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
Euro40.57B
PE
29.10
EV/EBITDA
25.7
DIV Yield
0.4%
Payout Ratio
12%
MQV Rating
2Strong
As at 18/09/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- Consensus Cheap
- HALO 100
- HALO 50
- HALO All
- HALO Capital Efficiency
- HALO Earnings Momentum
- HALO GARP
- HALO Growth
- HALO Small
Key Fundamentals
EPS 3 yr Growth
271.80%
EBITDA Margin
23.20%
Operating Cashflow
€2,163m
Free Cash Flow Return
16.60%
ROIC
12.00%
Interest Coverage
14.00
Quick Ratio
1.00
Performance
52 weeks range
Low 191.2 - 289.5
Trade Value (12mth)
US$17,239,712.00
1 week
3.42%
1 month
-4.27%
YTD
-10.93%
1 year
2%
All time high
289.50
Additional Data
Shares Outstanding (Fully Diluted)
194m
HALO Sector
Healthcare
Next Company Report Date
25-Feb-27
Next Ex Dividend Date
04-May-26
Next Dividend Pay Date
06-May-26
Reporting Currency
EUR
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Strong
Garp
Very Strong
Mqv Small
Strong
Momentum
Price
Very Weak
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Strong
Valuation
Value
Consensus
Yield
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Financière de Tubize SA | Public Company |
| UCB SA | Public Company |
| OrbiMed Advisors Private Equity | Subsidiary |
| Mirova SA | Subsidiary |
| Lord Abbett (Ireland) Ltd. | Private Company |
